Search research articles
Contact Us
Filters
Showing results (1-10 of 108) with videos related to
Page
of 11
Sort By:
Gastroenterology
|
November 28, 2002
Neuropathology of IBS?
Robin C Spiller
Cellular and Molecular Gastroenterology and Hepatology
|
September 6, 2018
Hidden Dangers of Antibiotic Use: Increased Gut Permeability Mediated by Increased Pancreatic Proteases Reaching the Colon
Robin C Spiller
Digestive Diseases (Basel, Switzerland)
|
March 6, 2010
Overlap between irritable bowel syndrome and inflammatory bowel disease
Robin C Spiller
Gastroenterology
|
May 23, 2003
Postinfectious irritable bowel syndrome
Robin C Spiller
Current Opinion in Pharmacology
|
March 15, 2011
Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome
Robin C Spiller
Gastroenterology Clinics of North America
|
May 3, 2005
Potential future therapies for irritable bowel syndrome: will disease modifying therapy as opposed to symptomatic control become a reality?
Robin C Spiller
The American Journal of Gastroenterology
|
February 20, 2003
Estimating the importance of infection in IBS
Robin C Spiller
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 8, 2004
Infection, immune function, and functional gut disorders
Robin C Spiller
British Medical Bulletin
|
March 16, 2005
Irritable bowel syndrome
Robin C Spiller
Digestive Diseases (Basel, Switzerland)
|
July 8, 2011
Irritable bowel syndrome: gender, infection, lifestyle or what else?
Robin C Spiller
Page
of 11
Search research articles
Search
Showing results (1-10 of 108) with videos related to
Sort By:
Page
of 11
Gastroenterology
|
November 28, 2002
Neuropathology of IBS?
Robin C Spiller
Cellular and Molecular Gastroenterology and Hepatology
|
September 6, 2018
Hidden Dangers of Antibiotic Use: Increased Gut Permeability Mediated by Increased Pancreatic Proteases Reaching the Colon
Robin C Spiller
Digestive Diseases (Basel, Switzerland)
|
March 6, 2010
Overlap between irritable bowel syndrome and inflammatory bowel disease
Robin C Spiller
Gastroenterology
|
May 23, 2003
Postinfectious irritable bowel syndrome
Robin C Spiller
Current Opinion in Pharmacology
|
March 15, 2011
Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome
Robin C Spiller
Gastroenterology Clinics of North America
|
May 3, 2005
Potential future therapies for irritable bowel syndrome: will disease modifying therapy as opposed to symptomatic control become a reality?
Robin C Spiller
The American Journal of Gastroenterology
|
February 20, 2003
Estimating the importance of infection in IBS
Robin C Spiller
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 8, 2004
Infection, immune function, and functional gut disorders
Robin C Spiller
British Medical Bulletin
|
March 16, 2005
Irritable bowel syndrome
Robin C Spiller
Digestive Diseases (Basel, Switzerland)
|
July 8, 2011
Irritable bowel syndrome: gender, infection, lifestyle or what else?
Robin C Spiller
Page
of 11